This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Helen Blade - Innovator in mTOR Kinase Inhibitors
Introduction
Helen Blade is a prominent inventor based in Macclesfield, GB. She has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds that target specific biological pathways.
Latest Patents
Helen Blade holds a patent for a process related to the preparation of novel pyridopyrazines as mTOR kinase inhibitors. This patent outlines a method for synthesizing a compound of Formula 1, which can be utilized in the preparation of a compound of Formula 5 or its various salts. The fumarate salt derived from this process is particularly noted for its therapeutic applications.
Career Highlights
Helen is currently employed at AstraZeneca, a leading global biopharmaceutical company. Her work focuses on innovative drug development, contributing to advancements in therapies that address critical health issues.
Collaborations
Throughout her career, Helen has collaborated with notable colleagues, including Benjamin Charles Dobson and Gwydion Huw Churchill. These partnerships have fostered a collaborative environment that enhances research and development efforts.
Conclusion
Helen Blade's contributions to the field of medicinal chemistry and her innovative patent work exemplify her commitment to advancing therapeutic solutions. Her ongoing efforts at AstraZeneca continue to impact the pharmaceutical industry positively.